SERPINB4
protein-codingserpin family B member 4, the group of Serpin peptidase inhibitors
Gene summary
The protein encoded by this gene is a member of the serpin family of serine protease inhibitors. The encoded protein is highly expressed in many tumor cells and can inactivate granzyme M, an enzyme that kills tumor cells. This protein, along with serpin B3, can be processed into smaller fragments that aggregate to form an autoantigen in psoriasis, probably by causing chronic inflammation. [provided by RefSeq, Jan 2017]
- SCCA2
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~7.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SERPINB4 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_002974.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 0 | |||||
| missense | 72 | 9 | 81 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 0 | 73 | 9 | 0 | 82 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_002965.1 | 7 | MANE Select | |
| Ensembl | ENSP00000343445.5 | 7 | MANE Select | |
| RefSeq | NP_778206.1 | 7 | Standard | |
| Ensembl | ENSP00000398645.1 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Amoebiasis - Homo sapiens (human)
Biological Process
- negative regulation of peptidase activity
- negative regulation of endopeptidase activity
- regulation of proteolysis
- protection from natural killer cell mediated cytotoxicity
Molecular Function
- protease binding
- serine-type endopeptidase inhibitor activity
- enzyme binding
Cellular Component
- extracellular space
- cytoplasm
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000341074
- Coding exons
- 7
- Length
- 7040
- Individuals with no LoFs
- 125324
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 385
- Defined
- 125709
- p
- 0.00153
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -1.87 | 279 | 204 | 1.37 | 0.00000994 | 2604 |
| Missense (PolyPhen) | 86 | 67.139 | 1.2809 | 913 | ||
| Synonymous | -3.14 | 115 | 79.4 | 1.45 | 0.00000447 | 685 |
| Loss of Function | -1.46 | 21 | 14.9 | 1.41 | 6.95e-7 | 182 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0027 | 0.0026 | notable |
| Latino/Admixed American | 0.0040 | 0.0040 | notable |
| Ashkenazi Jewish | 0.00070 | 0.00069 | rare |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0.000092 | 0.000092 | rare |
| European (Non-Finnish) | 0.0015 | 0.0015 | notable |
| South Asian | 0.00027 | 0.00026 | rare |
| Other | 0.0021 | 0.0021 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May act as a protease inhibitor to modulate the host immune response against tumor cells.;
Recessive Scores
- pRec
- 0.117
Intolerance Scores
- LoFtool
- 0.235
- RVIS EVS
- -0.33
- RVIS percentile EVS
- 30.7
Essentials
- Essential (CRISPR)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.534
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |